Medtronic (NYSE: MDT) gains as CMS published a proposed NCD decision memo for Renal Denervation (RDN).Evercore ISI analyst Vijay ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE